BandLevel 5 Job Description SummaryHeading the Veterinary Medicine group (VM) with the aim of guaranteeing flawless veterinary care including clinical monitoring/treatment and health & hygiene monitoring of all laboratory animal colonies as well as support of
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)